enVVeno Medical - About the company
enVVeno Medical is a public company based in Irvine (United States), founded in 1999 by Norman Jaffe. It operates as a Developer of medical device for the the treatment of venous diseases. enVVeno Medical has raised $874K in funding. The company has 47 active competitors, including 13 funded and 7 that have exited. Its top competitors include companies like Tactile Medical, Intervene and ElastiMed.
Company Details
Developer of medical device for the the treatment of venous diseases. The company is focused on the development of bioprosthetic solutions VenoValve an implant for the treatment of deep venous chronic venous insufficiency to assist in propelling blood up the leg, and back to the heart and lungs.
- Website
- envveno.com
- Social
- Phone Number
- +1 **********
Key Metrics
Founded Year
1999
Location
Irvine, United States
Stage
Public
Total Funding
$874K in 6 rounds
Latest Funding Round
Investors
Ranked
5th among 47 active competitors
Annual Revenue
$0 - $1M as on Dec 31, 2019
Employee Count
28 as on Oct 31, 2026
Similar Companies
Exit Details
Public
Legal entities associated with enVVeno Medical
enVVeno Medical is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Envveno Medical Corp CIN: 1661053 , United States, Active | $0 - $1M (As on Dec 31, 2019) | 31 (As on Feb 29, 2024) | - | |
ENVVENO MEDICAL CORPORATION CIN: 330936180 , United States, Active | Dec 21, 1999 | - | 35 (As on Dec 31, 2024) | - |
enVVeno Medical's IPO details
enVVeno Medical got listed on May 29, 2018.
Click here to take a look at enVVeno Medical's IPO in detail
Sign up to download enVVeno Medical's company profile
enVVeno Medical's funding and investors
enVVeno Medical has raised a total funding of $874K over 6 rounds. Its first funding round was on Dec 15, 2015. Its latest funding round was a Post IPO round on Oct 06, 2023 for $*****. 5 investors participated in its latest round. enVVeno Medical has 5 institutional investors.
Here is the list of recent funding rounds of enVVeno Medical:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 06, 2023 | 3001932 | Post IPO | 3484303 | 6082086 | 6018523 | 4566088 |
Aug 04, 2020 | 7583514 | Post IPO | 5327402 | 7719253 | 4034779 | 3106572 |
Mar 10, 2020 | 5177481 | Post IPO | 3064058 | 1179784 | 4428937 | 3519518 |
Access funding benchmarks and valuations. Sign up today!View details of enVVeno Medical's funding rounds and investors
enVVeno Medical's founders and board of directors
Founder? Claim ProfileThe founders of enVVeno Medical is Norman Jaffe. Robert Berman is the CEO of enVVeno Medical.
Here are the details of enVVeno Medical's key team members:
- Norman Jaffe: Founder of enVVeno Medical.
- Robert Berman: CEO of enVVeno Medical. Contact Info: 1 email address
View details of enVVeno Medical's Founder profiles and Board Members
enVVeno Medical's employee count trend
enVVeno Medical has 28 employees as of Oct 26. Here is enVVeno Medical's employee count trend over the years:
Uncover enVVeno Medical's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
enVVeno Medical's Competitors and alternates
Top competitors of enVVeno Medical include Tactile Medical, Intervene and ElastiMed. Here is the list of Top 10 competitors of enVVeno Medical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Tactile Medical 1995, Minneapolis (United States), Public | Provider of lymphedema and venous ulcer treatment therapy and pumps | $23.2M | 65/100 | |
2nd | Intervene 2003, Derby (United Kingdom), Series B | Medical device company that develops catheter based therapy for chronic venous insufficieny (CVI) | $37.6M | 55/100 | |
3rd | Wearable compression stocking to prevent Deep vein thrombosis | $4.2M | 53/100 | ||
4th | Micro Medical Solutions 2014, Wilmington (United States), Series B | Developer of a device for CLI and PAD patients to prevent amputation | $17.8M | - | 52/100 |
5th |  enVVeno Medical 1999, Irvine (United States), Public | Developer of medical device for the the treatment of venous diseases | $874K | 50/100 | |
6th |  InVera Medical 2018, Galway (Ireland), Seed | Manufacturer of medical devices for the office-based treatment of chronic venous disease | $5.34M | 46/100 | |
7th |  Sky Medical Technology 2006, High Wycombe (United Kingdom), Series B | Electro stimulation devices for treatment of Deep vein thrombosis | $48.7M | 42/100 | |
8th |  DeVoro Medical 2018, Fremont (United States), Acquired | Developer of medical devices for the treatment of cardiac diseases | $18M | 41/100 | |
9th | MCS 2012, Concord (United States), Funding Raised | Developer of a compression system for treating deep vein thrombosis | - | 41/100 | |
10th | Recovery Force 2013, Indianapolis (United States), Series B | Wearable massage compression sleeves and wraps | $16.3M | 39/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on enVVeno Medical's competitors? Click here to see the top ones
enVVeno Medical's Investments and acquisitions
enVVeno Medical has made no investments or acquisitions yet.
Reports related to enVVeno Medical
Here is the latest report on enVVeno Medical's sector:
News related to enVVeno Medical
Filter this listMedia has covered enVVeno Medical for a total of 5 events in the last 1 year, 2 of them have been about company updates.
•
enVVeno Medical Reports Third Quarter 2026 Financial Results and Prepares to Treat First Patients in FDA-Approved TAVVE Pivotal StudyAccess Newswire•Oct 30, 2026•enVVeno Medical
•
enVVeno Medical Publishes Landmark Health Economic Study Showing VenoValve Dominates Standard of Care as enVVe Pivotal Study AdvancesPrismmarketview•Aug 04, 2026•enVVeno Medical
•
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal TrialAccess Newswire•Jul 07, 2026•enVVeno Medical
•
NorthStrive Calls on enVVeno to Halt Clinical Spending, Calls for Shareholder VoteGlobeNewswire•Mar 04, 2026•enVVeno Medical
•
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate UpdateAccess Newswire•Oct 31, 2025•enVVeno Medical
•
enVVeno Medical Updates Regulatory Status of VenoValve(R)Access Newswire•Sep 15, 2025•enVVeno Medical
•
enVVeno Medical to Present at Webull Financial Corporate Connect WebinarWebDisclosure•Aug 15, 2025•enVVeno Medical
•
enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Access Newswire•Aug 01, 2025•enVVeno Medical
•
enVVeno Medical appoints Jennifer Bright as financial chiefSeeking Alpha•May 19, 2025•enVVeno Medical
•
Westside Investment Management Inc. Has $4.11 Million Holdings in Northrop Grumman Co. (NYSE:NOC)MarketBeat•Jan 23, 2025•Westside Im, Northrop Grumman, enVVeno Medical
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about enVVeno Medical
Explore our recently published companies
- Fullfinity - Unfunded company
- Fielio - Peru based, Unfunded company
- FenTek - Unfunded company
- Fdx AI - Unfunded company
- OrgRise AI - Unfunded company
- Vijya Comptech - India based, Unfunded company
